Minimally invasive surgery

Robotic da Vinci surgery

Certified console surgeon · da Vinci Xi™

The most advanced form of minimally invasive surgery for digestive cancers: superior precision, incisions of a few millimetres and fast recovery — with the surgeon in full control at every step.

Verified profile · robotic surgery directory →
Assoc. Prof. Valentin Calu, MD, at the da Vinci Xi surgical console
For patients

What is the da Vinci surgical system?

The da Vinci system is a surgical platform that allows operating through a few incisions of just millimetres, with a precision superior to conventional surgery. One thing is essential to understand: the robot does not operate on its own and makes no decisions. Every movement is controlled in real time by the surgeon, seated at a console in the same operating room.

The robot is, in fact, an extremely fine extension of the surgeon's hands — an instrument that translates their gestures into movements more precise than would otherwise be possible.

How it works

The surgeon's vision, hands and precision — amplified

Vision

Magnified 3D imaging

The surgeon looks through a high-definition three-dimensional camera that magnifies the operating field up to ten times. Fine structures — nerves, small vessels — become far clearer than with the naked eye.

Hands

Tremor-free, wide articulation

The surgeon's hands operate two controls, and the instruments inside reproduce the movements — filtered of any tremor and with greater flexibility than the human wrist.

Access

Precision in narrow spaces

In difficult anatomical spaces — such as the pelvis, in rectal cancer — the robot offers access and control where precision matters most.

Benefits

What it means for you

01

Less pain, minimal scars

Incisions of a few millimetres mean less pain after surgery and almost invisible marks.

02

Faster recovery

Early mobilisation and a shorter hospital stay, with a faster return to normal life.

03

Preserving delicate functions

In rectal cancer, precision allows protection of the nerves controlling urinary and sexual function.

04

Fewer conversions to open surgery

An operation begun minimally invasively is more likely to stay that way, without the need for a large incision.

What the studies say

A synthesis of the evidence

Research over recent years — including large clinical trials and meta-analyses — shows a balanced picture. Robotic surgery reduces the need to convert the operation to open surgery and, in rectal cancer, tends to offer a more complete excision of tissue and a higher number of examined lymph nodes — markers of oncological quality.

For many other outcomes — complications, overall safety, long-term survival — robotic and laparoscopic surgery performed by experienced hands give comparable results. This is in fact good news: both are excellent techniques. Robotics has the drawback of a somewhat longer operating time and a higher cost.

It is not the technology itself that cures, but the surgeon who masters it. The da Vinci system is a remarkable instrument in the right hands — and the choice between the robotic and laparoscopic approach is made individually, according to the location and stage of your disease.

Scientific references

  1. Jayne D, Pigazzi A, Marshall H, et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017;318(16):1569–1580.
  2. Feng Q, Yuan W, Li T, et al. Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. The Lancet Gastroenterology & Hepatology. 2022;7(11):991–1004.
  3. Li X, Xu L, Shen X, Li H. Comparison of surgical outcomes between robotic and laparoscopic surgery for mid-low rectal cancer: a meta-analysis of randomized controlled trials. Journal of Robotic Surgery. 2025;19(1):177.
  4. Systematic Review and Meta-Analysis of Laparoscopic versus Robotic-Assisted Surgery for Colon Cancer (studies 2020–2024), 21 studies, 50,771 patients. PRISMA systematic review, 2024.
Get started

Find out whether the robotic approach is right for you.

At the consultation we discuss the treatment options together, according to your diagnosis and the stage of disease.

Request a second opinion